Evidence map›Paper›PMID 35017107›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Evidence of SARS-CoV-2 symptomatic reinfection in four healthcare professionals from the same hospital despite the presence of antibodies.

Saba Gargouri, Amal Souissi, Nabil Abid, Amel Chtourou, Lamia Feki-Berrajah, Rim Karray, Hana Kossentini, Ikhlass Ben Ayed, Fatma Abdelmoula, Olfa Chakroun and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  8. Reply to letter to the editor by Lippi and Plebani: « The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization » (THEIJID-D-22-00085).International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Saba GargouriDepartment of Microbiology, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Amal SouissiLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Tunisia.
Nabil AbidLaboratory of Transmissible Diseases and Biological Active Substances, Faculty of Pharmacy of Monastir, University of Monastir, Tunisia; High Institute of Biotechnology of Monastir, University of Monastir, Tunisia.
Amel ChtourouDepartment of Microbiology, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Lamia Feki-BerrajahDepartment of Microbiology, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Rim KarrayEmergency Department, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Hana KossentiniEmergency Department, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Ikhlass Ben AyedLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Tunisia.
Fatma AbdelmoulaLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Tunisia.
Olfa ChakrounEmergency Department, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Abdennour NasriEmergency Department, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Adnène HammamiDepartment of Microbiology, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Noureddine RekikEmergency Department, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Saber MasmoudiLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Tunisia.
Hela Karray-HakimDepartment of Microbiology, Habib Bourguiba University Hospital/Faculty of Medicine of Sfax, University of Sfax, Tunisia.
Ahmed RebaiLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Tunisia. Electronic address: ahmed.rebai@gmail.com.
University of Sfax · TNUniversity of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSince the onset of the COVID-19 pandemic, cases of reinfection with SARS-CoV-2 have been reported, raising additional public health concerns. SARS-CoV-2 reinfection was assessed in healthcare workers (HCWs) in Tunisia because they are at the greatest exposure to infection by different variants.

methodsWe conducted whole-genome sequencing of the viral RNA from clinical specimens collected during the initial infection and the suspected reinfection from 4 HCWs, who were working at the Habib Bourguiba University Hospital (Sfax, Tunisia) and retested positive for SARS-CoV-2 through reverse transcriptase-polymerase chain reaction (RT-PCR) after recovery from a first infection. A total of 8 viral RNAs from the patients' respiratory specimens were obtained, which allowed us to characterize the differences between viral genomes from initial infection and positive retest. The serology status for total Ig, IgG, and IgM against SARS-CoV-2 was also determined and followed after the first infection.

resultsWe confirmed through whole-genome sequencing of the viral samples that all 4 cases experienced a reinfection event. The interval between the 2 infection events ranged between 45 and 141 days, and symptoms were milder in the second infection for 2 patients and more severe for the remaining 2 patients. Reinfection occurred in all 4 patients despite the presence of antibodies in 3 of them.

conclusionThis study adds to the rapidly growing evidence of COVID-19 reinfection, where viral sequences were used to confirm infection by distinct isolates of SARS-CoV-2 in HCWs. These findings suggest that individuals who are exposed to different SARS-CoV-2 variants might not acquire sufficiently protective immunity through natural infection and emphasize the necessity of their vaccination and the regular follow-up of their immune status both in quantitative and qualitative terms.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralDelivery of Health CareHealth PersonnelHospitalsHumansPandemicsReinfectionAntibodies, ViralCoronavirus disease 2019Healthcare professionalReinfectionSARS-CoV-2

Identifiers

PMID35017107
PMCPMC8743858
OpenAlexW4205313206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.